Loteprednol etabonate eye drops 0.5% (Lotemax)
- BNF:
- 11.4.1
- Status:
- Red
- Decision Date:
- March 2025
Comments
RED: for prescribing within secondary care or specialist community optometry servicesRed Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
search again